Regenerative Medical Technology Group Inc. Net Income Loss

• Regenerative Medical Technology Group Inc. showed an increase of +43.3% in Net Income Loss from 2023 to 2024.
• This data is from Regenerative Medical Technology Group Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
• XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2017 to 2024), Regenerative Medical Technology Group Inc.'s Net Income Loss has declined by 1,375.6%.
• Historical annual values: Fiscal year 2024: -$5.56 million | Fiscal year 2023: -$9.81 million | Fiscal year 2022: -$5.51 million | Fiscal year 2021: -$12.88 million | Fiscal year 2020: -$5.90 million | Fiscal year 2019: -$2.51 million | Fiscal year 2018: -$2.06 million | Fiscal year 2017: -$377.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026